Dawn Furey, (Former) Executive Director / Head of Global Operations, Merck
Dawn Furey on ways the industry can improve in the future and the transparent and honest working relationship she has experienced when working with DrugDev.
Brenda Medina, Associate Director, Head of Analytics, BioMarin
Brenda discusses the challenges of working within a data driven industry and how DrugDev is helping to overcome some of these issues.
Ana Marquez, CEO, Marquez Clinical Site Partners
Ana on overcoming industry challenges and how DrugDev payments can help all sites with payment and other issues.
Tom Haag, Learning and Process Lead, Novartis
Tom Haag says he’d like to see his job disappear before going on to describe the direction he would like to see clinical trials go in over the next 5 years and compliments DrugDev on the direction we are headed.
Chris Conklin, Director Feasibility Center of Excellence, Pfizer
Chris discusses DrugDev’s mission to make things easier for sites and the challenge of making ever more complex protocols easy to execute whilst ensuring the scientific questions are answered.
Joanne Wilkinson, Senior Research Coordinator, Population Health Research Institute
Joanne on how DrugDev has helped Population Health Research overcome communication challenges in large global trials and how e-consent can help trials become more efficient and global.
